Welcome
Support Centre
06 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
The long term effectiveness of steroid injection for shoulder pain; a pragmatic randomised comparison with physiotherapy in primary care
ISRCTN ISRCTN24540377
ClinicalTrials.gov identifier
Public title The long term effectiveness of steroid injection for shoulder pain; a pragmatic randomised comparison with physiotherapy in primary care
Scientific title
Acronym N/A
Serial number at source H0563
Study hypothesis To compare the long term effectiveness of local steroid injections administered by general practitioners with practice based physiotherapy for treating patients presenting in primary care with new episodes of unilateral shoulder pain.
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Shoulder pain
Participants - inclusion criteria 1. Males and females over 18 years with a clinical diagnosis of unilateral shoulder pain
2. First consultation with GP for this episode
3. Ability to understand and give informed consent
Participants - exclusion criteria A history of inflammatory arthritis, polymyalgia rheumatica, or gross structural or neurological abnormality of the shoulder; contraindications to local steroid injection; history or examination leading to a suspicion of potentially serious disease; referred pain from neck or internal organs; clinical findings of ruptured rotator cuff; previous fracture or surgery to shoulder, upper limb, neck, or thorax; previous physical therapy for shoulder pain within the past 12 months; pregnancy or breast feeding.
Anticipated start date 01/06/1998
Anticipated end date 30/09/2000
Status of trial Completed
Patient information material
Target number of participants 207
Interventions 1. Methyl prednisolone (40 mg) and lignocaine by local injection
2. Physiotherapy
Primary outcome measure(s) The primary outcome was disability at 6 months measured using a shoulder disability Questionnaire.
Secondary outcome measure(s) Secondary outcomes included: participants’ global assessment of change compared with baseline; rating of pain severity; impairment of function; severity of main complaint; ranges of movement; co-interventions.
Sources of funding Arthritis Research Campaign
Trial website
Publications 1. Results in http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12695148
2. Results in http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14965386
Contact name Dr  EM  Hay
  Address Department of Rheumatology
Haywood Hospital
High Lane
Burslem
  City/town Stoke-on-Trent
  Zip/Postcode ST6 7AG
  Country United Kingdom
  Tel +44 (0)1782 715444
  Email e.m.hay@cphc.keele.ac.uk
Sponsor Arthritis Research Campaign (ARC) (UK)
  Address Copeman House
St Mary's Court
St Mary's Gate
Chesterfield
  City/town Derbyshire
  Zip/Postcode S41 7TD
  Country United Kingdom
  Email info@arc.org.uk
  Sponsor website: http://www.arc.org.uk
Date applied 03/01/2003
Last edited 11/07/2007
Date ISRCTN assigned 03/01/2003
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central